mRNA COVID-19 vaccine effectiveness wanes to as low 23 per cent from seven months, while homologous vaccination with ChAdOx1 delivers no detectable effectiveness from four months onwards, according to a study published in The Lancet .

The retrospective cohort study used data from Swedish nationwide registers from all individuals vaccinated...